NIH/NIDCR Funding from
Economic Stimulus Package
New Funding Opportunities
(6-09) NIH has announced several new funding opportunities that will be supported with funds made available under the American Recovery and Reinvestment Act (ARRA). Specifically, ARRA funds will be allocated for:
Small Business Catalyst Awards for Accelerating Innovative Research (R43)
The Small Business Catalyst awards focus on early stage technology development. Grant applications are invited from small business concerns who propose to accelerate innovation through high risk, high reward research and development (R&D) that has commercial potential and is relevant to NIH's mission. In particular, applications from small business concerns without a history of NIH Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) support may receive funding priority. Rather than focusing on incremental improvements of existing technologies, projects should have the potential to generate high impact results (e.g., products, processes or services) and/or innovative research applications, research tools, techniques, devices, inventions, or methodologies.
NIH intends to commit at least $5 million for the Small Business Catalyst awards and anticipates that 20-25 awards will be made for FY 2010, pending the number and quality of applications received and availability of funds. Letters of intent are due August 3, 2009; applications are due September 1, 2009. For additional details see:
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-009.html
New Technologies (BRDG-SPAN) Pilot Program (RC3)
Grant applications are invited for a new initiative called Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3). The program aims to address the funding gap between promising R&D and the transition to market by contributing to critical funding needed by applicants to pursue the later stage research activities necessary to achieve ultimate commercialization. The goal is to accelerate the transition from research innovations and technologies to the development of products or services that will improve human health, advance NIH's mission, and create significant value and economic stimulus. The program also aims to foster partnerships among a variety of R&D collaborators working toward these goals.
NIH intends to commit at least $35 million in response to this program and anticipates that at least 10 awards will be made in FY 2010, pending the number and quality of applications received and the availability of funds. Letters of intent are due August 3, 2009; applications are due September 1, 2009. For additional details see:
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-008.html
Academic Research Enhancement Awards (R15)
The Academic Research Enhancement Awards (AREA) are intended to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. The AREA grants will create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH programs, to contribute to the Nation's biomedical and behavioral research effort. AREA grants will support small-scale, health-related research projects proposed by faculty members of eligible, domestic institutions. Applications are due September 24, 2009. For additional details see:
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-007.html
For additional details, see NIDCR's ARRA website: http://www.nidcr.nih.gov/Recovery/ |
